Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury (original) (raw)

• Humphreys, B.D. et al. Intrinsic epithelial cells repair the kidney after injury. Cell Stem Cell 2, 284–291 (2008).
  Article CAS Google Scholar
• Wynn, T.A. Cellular and molecular mechanisms of fibrosis. J. Pathol. 214, 199–210 (2008).
  Article CAS Google Scholar
• Coresh, J., Astor, B.C., Greene, T., Eknoyan, G. & Levey, A.S. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am. J. Kidney Dis. 41, 1–12 (2003).
  Article Google Scholar
• Lameire, N., Jager, K., Van Biesen, W., de Bacquer, D. & Vanholder, R. Chronic kidney disease: a European perspective. Kidney Int. Suppl. S30–S38 (2005).
• Forbes, J.M., Hewitson, T.D., Becker, G.J. & Jones, C.L. Ischemic acute renal failure: long-term histology of cell and matrix changes in the rat. Kidney Int. 57, 2375–2385 (2000).
  Article CAS Google Scholar
• Macedo, E., Bouchard, J. & Mehta, R.L. Renal recovery following acute kidney injury. Curr. Opin. Crit. Care 14, 660–665 (2008).
  Article Google Scholar
• Kalluri, R. & Neilson, E.G. Epithelial-mesenchymal transition and its implications for fibrosis. J. Clin. Invest. 112, 1776–1784 (2003).
  Article CAS Google Scholar
• Liu, Y. Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J. Am. Soc. Nephrol. 15, 1–12 (2004).
  Article CAS Google Scholar
• Burns, W.C., Kantharidis, P. & Thomas, M.C. The role of tubular epithelial-mesenchymal transition in progressive kidney disease. Cells Tissues Organs 185, 222–231 (2007).
  Article CAS Google Scholar
• Humphreys, B.D. et al. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am. J. Pathol. 176, 85–97 (2010).
  Article CAS Google Scholar
• Nguyen, T.Q. & Goldschmeding, R. Bone morphogenetic protein-7 and connective tissue growth factor: novel targets for treatment of renal fibrosis? Pharm. Res. 25, 2416–2426 (2008).
  Article CAS Google Scholar
• Qi, W., Chen, X., Poronnik, P. & Pollock, C.A. Transforming growth factor-β/connective tissue growth factor axis in the kidney. Int. J. Biochem. Cell Biol. 40, 9–13 (2008).
  Article CAS Google Scholar
• Bonventre, J.V. Dedifferentiation and proliferation of surviving epithelial cells in acute renal failure. J. Am. Soc. Nephrol. 14 Suppl 1, S55–S61 (2003).
  Article Google Scholar
• Price, P.M., Megyesi, J. & Safirstein, R.L. Cell cycle regulation: repair and regeneration in acute renal failure. Kidney Int. 66, 509–514 (2004).
  Article CAS Google Scholar
• Tanaka, H. et al. Role of the E2F1-p19-p53 pathway in ischemic acute renal failure. Nephron Physiol. 101, 27–34 (2005).
  Article Google Scholar
• Chkhotua, A.B., Abendroth, D., Froeba, G. & Schelzig, H. Up-regulation of cell cycle regulatory genes after renal ischemia/reperfusion: differential expression of p16(INK4a), p21(WAF1/CIP1) and p27(Kip1) cyclin-dependent kinase inhibitor genes depending on reperfusion time. Transpl. Int. 19, 72–77 (2006).
  Article CAS Google Scholar
• Melk, A., Schmidt, B.M., Vongwiwatana, A., Rayner, D.C. & Halloran, P.F. Increased expression of senescence-associated cell cycle inhibitor p16INK4a in deteriorating renal transplants and diseased native kidney. Am. J. Transplant. 5, 1375–1382 (2005).
  Article CAS Google Scholar
• Jiang, M. & Dong, Z. Regulation and pathological role of p53 in cisplatin nephrotoxicity. J. Pharmacol. Exp. Ther. 327, 300–307 (2008).
  Article CAS Google Scholar
• Price, P.M., Safirstein, R.L. & Megyesi, J. The cell cycle and acute kidney injury. Kidney Int. 76, 604–613 (2009).
  Article Google Scholar
• Molitoris, B.A. et al. siRNA targeted to p53 attenuates ischemic and cisplatin-induced acute kidney injury. J. Am. Soc. Nephrol. 20, 1754–1764 (2009).
  Article CAS Google Scholar
• Yu, C.C., Woods, A.L. & Levison, D.A. The assessment of cellular proliferation by immunohistochemistry: a review of currently available methods and their applications. Histochem. J. 24, 121–131 (1992).
  Article CAS Google Scholar
• Crosio, C. et al. Mitotic phosphorylation of histone H3: spatio-temporal regulation by mammalian Aurora kinases. Mol. Cell. Biol. 22, 874–885 (2002).
  Article CAS Google Scholar
• Silva, F.G., Nadasdy, T. & Laszik, Z. Immunohistochemical and lectin dissection of the human nephron in health and disease. Arch. Pathol. Lab. Med. 117, 1233–1239 (1993).
  CAS PubMed Google Scholar
• Ichimura, T., Hung, C.C., Yang, S.A., Stevens, J.L. & Bonventre, J.V. Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury. Am. J. Physiol. Renal Physiol. 286, F552–F563 (2004).
  Article CAS Google Scholar
• Hendzel, M.J. et al. Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation. Chromosoma 106, 348–360 (1997).
  Article CAS Google Scholar
• Abraham, R.T. Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev. 15, 2177–2196 (2001).
  Article CAS Google Scholar
• Goodarzi, A.A., Block, W.D. & Lees-Miller, S.P. The role of ATM and ATR in DNA damage-induced cell cycle control. Prog. Cell Cycle Res. 5, 393–411 (2003).
  PubMed Google Scholar
• Bencokova, Z. et al. ATM activation and signaling under hypoxic conditions. Mol. Cell. Biol. 29, 526–537 (2009).
  Article CAS Google Scholar
• Hickson, I. et al. Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM. Cancer Res. 64, 9152–9159 (2004).
  Article CAS Google Scholar
• Komarov, P.G. et al. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 285, 1733–1737 (1999).
  Article CAS Google Scholar
• Vassilev, L.T. et al. Selective small-molecule inhibitor reveals critical mitotic functions of human CDK1. Proc. Natl. Acad. Sci. USA 103, 10660–10665 (2006).
  Article CAS Google Scholar
• Horwitz, S.B. Mechanism of action of taxol. Trends Pharmacol. Sci. 13, 134–136 (1992).
  Article CAS Google Scholar
• Ishani, A. et al. Acute kidney injury increases risk of ESRD among elderly. J. Am. Soc. Nephrol. 20, 223–228 (2009).
  Article Google Scholar
• Leask, A. & Abraham, D.J. TGF-β signaling and the fibrotic response. FASEB J. 18, 816–827 (2004).
  Article CAS Google Scholar
• Zeisberg, M. et al. Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J. Biol. Chem. 282, 23337–23347 (2007).
  Article CAS Google Scholar
• Qi, W. et al. Integrated actions of transforming growth factor-β1 and connective tissue growth factor in renal fibrosis. Am. J. Physiol. Renal Physiol. 288, F800–F809 (2005).
  Article CAS Google Scholar
• Okada, H. et al. Connective tissue growth factor expressed in tubular epithelium has a pivotal role in renal fibrogenesis. J. Am. Soc. Nephrol. 16, 133–143 (2005).
  Article CAS Google Scholar
• Ikawa, Y. et al. Neutralizing monoclonal antibody to human connective tissue growth factor ameliorates transforming growth factor-β–induced mouse fibrosis. J. Cell. Physiol. 216, 680–687 (2008).
  Article CAS Google Scholar
• Shi-Wen, X., Leask, A. & Abraham, D. Regulation and function of connective tissue growth factor/CCN2 in tissue repair, scarring and fibrosis. Cytokine Growth Factor Rev. 19, 133–144 (2008).
  Article Google Scholar
• Stark, G.R. & Taylor, W.R. Control of the G2/M transition. Mol. Biotechnol. 32, 227–248 (2006).
  Article CAS Google Scholar
• Taylor, W.R. & Stark, G.R. Regulation of the G2/M transition by p53. Oncogene 20, 1803–1815 (2001).
  Article CAS Google Scholar
• Bunz, F. et al. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282, 1497–1501 (1998).
  Article CAS Google Scholar
• Kailong, L. et al. P53-Rb signaling pathway is involved in tubular cell senescence in renal ischemia/reperfusion injury. Biocell 31, 213–223 (2007).
  PubMed Google Scholar
• Megyesi, J., Price, P.M., Tamayo, E. & Safirstein, R.L. The lack of a functional p21(WAF1/CIP1) gene ameliorates progression to chronic renal failure. Proc. Natl. Acad. Sci. USA 96, 10830–10835 (1999).
  Article CAS Google Scholar
• Zahedi, K. et al. Stathmin-deficient mice develop fibrosis and show delayed recovery from ischemic-reperfusion injury. Am. J. Physiol. Renal Physiol. 290, F1559–F1567 (2006).
  Article CAS Google Scholar
• Hong, H. et al. Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature 460, 1132–1135 (2009).
  Article CAS Google Scholar
• Kawamura, T. et al. Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature 460, 1140–1144 (2009).
  Article CAS Google Scholar
• Marion, R.M. et al. A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature 460, 1149–1153 (2009).
  Article CAS Google Scholar
• Ma, F.Y., Sachchithananthan, M., Flanc, R.S. & Nikolic-Paterson, D.J. Mitogen activated protein kinases in renal fibrosis. Front. Biosci. (Schol. Ed.) 1, 171–187 (2009).
  Article Google Scholar
• Park, K.M. et al. Inducible nitric oxide synthase is an important contributor to prolonged protective effects of ischemic preconditioning in the mouse kidney. J. Biol. Chem. 278, 27256–27266 (2003).
  Article CAS Google Scholar
• Hung, C.C., Ichimura, T., Stevens, J.L. & Bonventre, J.V. Protection of renal epithelial cells against oxidative injury by endoplasmic reticulum stress preconditioning is mediated by ERK1/2 activation. J. Biol. Chem. 278, 29317–29326 (2003).
  Article CAS Google Scholar
• Ichimura, T. et al. Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells. J. Clin. Invest. 118, 1657–1668 (2008).
  Article CAS Google Scholar